(Q33299018)

English

Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

object named as

Eric O Mick

2

0 references

Joseph Biederman

1

object named as

Joseph Biederman

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Craig Surman

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Robert Doyle

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Paul Hammerness

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Evan Michel

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Jessica Martin

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Thomas J Spencer

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

14 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

14 September 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075491

21 June 2018

Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075491

21 June 2018

A rating scale for depression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075491

21 June 2018

The assessment of anxiety states by rating

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075491

21 June 2018

Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075491

21 June 2018

Methylphenidate effects on symptoms of attention deficit disorder in adults.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075491

21 June 2018

Attention deficit disorders in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075491

21 June 2018

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075491

21 June 2018

Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075491

21 June 2018

The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-49

21 January 2018

Gender effects on attention-deficit/hyperactivity disorder in adults, revisited.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-49

21 January 2018

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-49

21 January 2018

A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-49

21 January 2018

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-49

21 January 2018

PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-49

21 January 2018

Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-7-49

21 January 2018

The Efficacy of 2 Different Dosages of Methylphenidate in Treating Adults with Attention-Deficit Hyperactivity Disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075491

31 October 2018

Adult attention-deficit/hyperactivity disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17868455

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-244X-7-49

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33299018&oldid=2195217320"